Remitted Early Phase Schizophrenia clinical trials

Explore recruiting remitted early phase schizophrenia clinical trials.

Also recruiting in Europe

Remitted Early Phase Schizophrenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CBD-ESPRIT - Enhancing recovery in early schizophrenia – a multi-center, two-arm, double-blind, randomized clinical trial investigating cannabidiol vs. placebo as an add-on to an individualized antipsychotic treatment

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Remitted Early Phase Schizophrenia trials by city

Remitted Early Phase Schizophrenia in Toronto Remitted Early Phase Schizophrenia in Vancouver Remitted Early Phase Schizophrenia in Montreal Remitted Early Phase Schizophrenia in Calgary Remitted Early Phase Schizophrenia in Edmonton Remitted Early Phase Schizophrenia in Ottawa Remitted Early Phase Schizophrenia in Winnipeg Remitted Early Phase Schizophrenia in Quebec City Remitted Early Phase Schizophrenia in Hamilton Remitted Early Phase Schizophrenia in Kitchener Remitted Early Phase Schizophrenia in London Remitted Early Phase Schizophrenia in Halifax Remitted Early Phase Schizophrenia in New York Remitted Early Phase Schizophrenia in Los Angeles Remitted Early Phase Schizophrenia in Chicago Remitted Early Phase Schizophrenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease